Literature DB >> 1091390

Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

L E Mather, G T Tucker, A E Pflug, M J Lindop, C Wilkerson.   

Abstract

The plasma concentration-time profiles of meperidine following intravenous injection in surgical patients and volunteers were investigated by reference to a classical two-compartment open model. Physiologic characteristics of the subject and variables associated with the surgery and anesthesia were screened as determinants of the kinetic patterns observed. When meperidine administration preceded induction of anesthesia, induction was consistently followed by an increase in venous plasma concentrations that prevented classical kinetic analysis. To facilitate calculations in subsequent studies in patients, meperidine injections were made following induction of anesthesia. Type of anesthesia or premedication, patients' sex, or cigarette smoking did not appear to be important factors in this evaluation. Increasing alcohol consumption was associated with increasing volumes of distribution. Increasing age was associated with increasing fraction of drug unbound in plasma. These factors may relate directly to clinical observations that heavy alcohol consumers tend to be more refractory to central nervous system (CNS) depressants and that elderly patients are more susceptible to respiratory depression from narcotics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091390     DOI: 10.1002/cpt197517121

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  53 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 3.  Anatomical-physiological approaches in pharmacokinetics and pharmacodynamics.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Pharmacokinetics in the aged: a review.

Authors:  E J Triggs; R L Nation
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

5.  The pharmacokinetics of chlormethiazole following intravenous administration in the aged.

Authors:  R L Nation; B Learoyd; J Barber; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

Review 6.  Pharmacokinetic optimisation of opioid treatment in acute pain therapy.

Authors:  R N Upton; T J Semple; P E Macintyre
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

7.  Meperidine-halothane interaction in dogs.

Authors:  E P Steffey; R Martucci; D Howland; J H Asling; J H Eisele
Journal:  Can Anaesth Soc J       Date:  1977-07

Review 8.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 9.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.